Antisense therapy promises to slow Huntington’s disease
13 December 2017
Drug injections into the spine sabotaged production of mutant protein that destroys brain cells
-
Subject
-
Section
-
Type
-
Topics
-
Author
-
Issue
-
Premium
Fentanyl considered for execution cocktail by two US states
13 December 2017
Nevada and Nebraska are considering using the opioid drug fentanyl to carry out death penalty executions
Victoria is first state in Australia to legalise euthanasia
6 December 2017
The parliament of Victoria passed the Voluntary Assisted Dying Bill last week, after more than 100 hours of debate
Two UK cities hit by measles outbreaks as vaccination rates drop
29 November 2017
Two cities were hit by measles outbreaks last week. There were 11 confirmed cases in Leeds, and eight in Liverpool, all in children who had not been vaccinated
Austerity cuts to NHS blamed for 120,000 excess deaths
22 November 2017
Excess deaths between 2010 and 2017 correlated most closely with a lack of nurses in care homes and cuts to community nursing
Digital drug tells your doctor when you've taken your medicine
15 November 2017
FDA approves an antipsychotic pill containing an electronic sensor that activates when it hits stomach fluid and sends a message to a smartphone-linked patch
NHS reforms have failed to boost community-based care in England
14 November 2017
Re-organising the National Health Service in England has failed to reduce the proportion of people being referred for expensive hospital treatments
FDA loosens rules on direct-to-consumer genetic tests
8 November 2017
The US Food and Drug Administration plans to loosen restrictions on the sale of direct-to-consumer genetic tests that predict health risks
WHO reverses decision to elect Robert Mugabe as ambassador
25 October 2017
The decision to rescind the appointment of the Zimbabwe president has raised questions over the leadership of the WHO’s first African director general Tedros Adhanom
IBM to investigate role of microbiome in autoimmune disorders
23 August 2017
A project launched by tech firm IBM plans to analyse millions of bacterial genes, in an effort to understand what causes type 1 diabetes and Crohn's disease
